Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Name: Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin
License: Public Domain

Lexicon Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type-2-diabetes-mellitus

type 2 diabetes mellitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184793
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.